Jacobi Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,398
Closed -$437K 1137
2019
Q3
$437K Sell
4,398
-7,284
-62% -$692K 0.09% 192
2019
Q2
$1.08M Buy
11,682
+450
+4% +$42.7K 0.22% 88
2019
Q1
$1.06M Sell
11,232
-54
-0.5% -$4.72K 0.27% 62
2018
Q4
$723K Buy
11,286
+4,718
+72% +$348K 0.2% 79
2018
Q3
$588K Buy
6,568
+73
+1% +$6.45K 0.16% 88
2018
Q2
$516K Buy
6,495
+764
+13% +$63.4K 0.15% 93
2018
Q1
$499K Buy
5,731
+601
+12% +$57.7K 0.15% 85
2017
Q4
$534K Buy
5,130
+1,551
+43% +$175K 0.17% 80
2017
Q3
$498K Buy
3,579
+1,010
+39% +$138K 0.17% 76
2017
Q2
$339K Buy
2,569
+105
+4% +$12.9K 0.13% 80
2017
Q1
$306K Buy
2,464
+2,314
+1,543% +$277K 0.16% 71
2016
Q4
$18K Sell
150
-549
-79% -$61.1K 0.01% 349
2016
Q3
$73K Hold
699
0.03% 189
2016
Q2
$73K Buy
+699
New +$72.3K 0.04% 180

Other funds holding CELG

Jacobi Capital Management's CELG Position: Q4 2019 in Review

Jacobi Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,398 shares — an estimated $437K sold.

Jacobi Capital Management first reported a position in CELG in Q2 2016 and held it in 14 quarters. The position peaked at $1.08M in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Jacobi Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Jacobi Capital Management sold 4,398 Celgene Corp shares in Q4 2019, an estimated $437K.
  • Jacobi Capital Management first reported a position in Celgene Corp in Q2 2016 and held it in 14 quarters.
  • Jacobi Capital Management's Celgene Corp position peaked at $1.08M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Jacobi Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.